ACRV Logo

Acrivon Therapeutics, Inc. Common Stock (ACRV) 

NASDAQ
Market Cap
$208.92M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
30 of 960
Rank in Industry
25 of 550

Largest Insider Buys in Sector

ACRV Stock Price History Chart

ACRV Stock Performance

About Acrivon Therapeutics, Inc. Common Stock

Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's Acrivon Predictive Precision Proteomics, a precision medicine platform enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate …

Insider Activity of Acrivon Therapeutics, Inc. Common Stock

Over the last 12 months, insiders at Acrivon Therapeutics, Inc. Common Stock have bought $20M and sold $0 worth of Acrivon Therapeutics, Inc. Common Stock stock.

On average, over the past 5 years, insiders at Acrivon Therapeutics, Inc. Common Stock have bought $33.68M and sold $97,579 worth of stock each year.

Highest buying activity among insiders over the last 12 months: PERCEPTIVE ADVISORS LLC (10 percent owner) — $360.01M.

The last purchase of 2,353,000 shares for transaction amount of $20M was made by PERCEPTIVE ADVISORS LLC (10 percent owner) on 2024‑04‑11.

List of Insider Buy and Sell Transactions, Acrivon Therapeutics, Inc. Common Stock

2024-04-11Purchase10 percent owner
2.35M
8.4743%
$8.50$20M-17.22%
2023-06-26Sale10 percent owner
16
<0.0001%
$12.93$207-48.66%
2023-06-15Sale10 percent owner
2,056
0.0106%
$12.14$24,960-39.33%
2023-06-14Sale10 percent owner
893
0.0046%
$12.13$10,832-38.40%
2023-06-13Sale10 percent owner
3,000
0.0156%
$12.30$36,900-40.28%
2023-06-12Sale10 percent owner
2,000
0.0105%
$12.34$24,680-40.91%
2022-11-17Purchase
3.39M
17.9519%
$12.50$42.37M-21.95%
2022-11-17Purchase10 percent owner
400,000
2.1185%
$12.50$5M-21.95%

Insider Historical Profitability

<0.0001%
PERCEPTIVE ADVISORS LLC10 percent owner
5360858
17.2174%
$6.7110
RA CAPITAL MANAGEMENT, L.P.
4384206
14.0807%
$6.7110<0.0001%
Chione Ltd10 percent owner
3848632
12.3606%
$6.7115<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.